Great ideas are the foundation of science, but funding makes great ideas become realities and a monopoly on funding hurts science. UPDATE: NIH data backs up our conclusions: overfunding wastes precious resources–give the money to smaller labs. Arguably the key driver of the exciting progress in stem cell research is funding. With the stakes so …
Stem cell monopoly: do not pass go, do not collect $200,000 Read More »
Reportedly, House Republicans are proposing a continuing resolution (CR) to fund the rest of FY2011 at 2008 funding levels. To achieve such an end, the Republicans would have to invoke serious cuts through the federal budget. Not only would such cuts likely damage the U.S. economy, but also they would have major other negative consequences. …
Last Fall’s mid-term election brought into office several new Republican Governors who during their campaigns used strong, anti-embryonic stem (ES) cell research rhetoric. For example, then candidate for Governor of Wisconsin, Scott Walker (now the Governor) used some of the strongest language, which was ironic considering that human ES cells were first produced in Wisconsin …
New Republican Governors Start Attack On Most Promising Stem Cell Research Read More »
Can one creature directly give another creature cancer? It appears so in dogs and that cancer is highly contagious. When we think about transplants of cells, we think about hospitals and high-tech equipment used to give patients stem cells or other types of cells to help treat them for a disease. Generally cancer patients are …
Contagious cancer: the allograft your dog doesn’t want Read More »
As we have blogged before, there are a host of different beliefs about embryonic stem cell research and about when life begins. This diversity of perspectives is sprinkled across the globe. Too often in the U.S. people take an ethnocentric view of this question, believing that everyone else should think the same as they do. …
A perspective on U.S. embryonic stem cell research from Israel Read More »
There is a kind of invisible cultural wall between patients such as cancer patients and biomedical scientists like me, but this wall does not have to exist and indeed it is a negative wall as patients, scientists, doctors, agencies, and advocates can achieve far more together than apart. But the wall is surprisingly strong. Last …
In 2010 I blogged about the exciting finding that researchers could derive most blood cell types from stem cells. You can read more about that here. Here also is a video of Micky Bhatia discussing the findings: Mick Bhatia on turning skin cells into blood. Now comes a new paper (you can read it here) from …
As the year comes to a close this week, it is a good time to look back on 2010 and consider the major events in the stem cell field and give out awards. Stem Cell Event of the Year. I would give this award as a dual prize to Geron and Advanced Cell Technology (ACT) …
What is the best way to get new stem cell-based therapies to the millions of patients who need help? I would argue that this is the key question in the field of stem cell biology and regenerative medicine. Sometimes I think it is easy for folks to lose sight of that and fall into traps. …
From Point A to Point Z: thinking outside the box about stem cells Read More »
The FDA has given Advanced Cell Technology (ACT) the go ahead to begin their clinical trial using retinal progenitor cells derived from hESC by clearing the company’s IND application, bringing hope to those with vision loss and even blindness. The trial will be a combined Phase I/II to treat Stargardt’s Macular Dystrophy and has huge …